1. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2022) Authors: Hardt, Karin; Vandebosch, An; Sadoff, Jerald; Le Gars, Mathieu; Truyers, Carla; Lowson, David; Van Dromme, Ilse; Vingerhoets, Johan; Kamphuis, Tobias; Scheper, Gert; Ruiz-Guiñazú, Javier; Faust, Saul N; Spinner, Christoph D; Schuitemaker, Hanneke; Van Hoof, Johan; Douoguih, Macaya; Struyf, Frank;... Journal: Lancet infectious diseases Issue: Volume 22:Issue 12(2022) Page Start: 1703 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial. Issue 10 (2nd October 2020) Authors: Turner, Mark; Papadimitriou, Athanasia; Winkle, Peter; Segall, Nathan; Levin, Michael; Doust, Matthew; Johnson, Casey; Lucksinger, Gregg; Fierro, Carlos; Pickrell, Paul; Raanan, Marsha; Tricou, Vianney; Borkowski, Astrid; Wallace, Derek Journal: Human vaccines & immunotherapeutics Issue: Volume 16:Issue 10(2020) Page Start: 2456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Poster 538 Gender Differences versus Genotype Risk of CoMorbidities in Chronic Pain Patients. Issue 9 (29th September 2014) Authors: Schwarz, Dan; Hubbard, John; Onojighofia, Tobore; Brian, Meshkin; Akindele, Bilikis; Holman, Derrick; Alderson, Nate; Doust, Matthew; Chen, Juetong Journal: PM&R Issue: Volume 6:Issue 9(2014)Supplement Page Start: S374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗